Skip to content

The use of carbon dioxide (CO2) as a contrast medium for performing endovascular procedures

The use of carbon dioxide (CO2) as a contrast medium for performing endovascular procedures

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-7v2vvt
Enrollment
Unknown
Registered
2012-05-11
Start date
2012-01-01
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lower limb ischemia caused by aortoiliac stenosis, lower limb ischemia due to stenosis of femoropopliteal Abdominal aortic aneurysm with an indication for endovascular repair.

Interventions

120 patients will undergo endovascular procedures: 40 for the treatment of lower limb ischemia caused by aortoiliac stenosis classified according to the consensus for the management of peripheral arte
40 for the treatment of lower limb ischemia due to stenosis femoropopliteal TASC A or B with an indication of angioplasty as the inclusion criteria and 40 for the treatment of abdominal aortic aneurys
drug
procedure/surgery

Sponsors

Hospital Israelita Albert Einstein
Lead Sponsor
Hospital Municipal M'boi Mirim - Dr. Moysés Deutsch
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: Patients with critical lower limb ischemia resulting from arterial disease morphology TASC A or B or abdominal aortic aneurysms with an indication for the correction ; Agreement and signing the informed consent.

Exclusion criteria

Exclusion criteria: Contraindications to any of the types of procedures either by the technique used, type of contrast or medical reasons.

Design outcomes

Primary

MeasureTime frame
Improve / complete resolution of the patient's condition coupled with the technical feasibility of using carbon dioxide as a contrast medium for performing endovascular procedures for treating patients with vascular disease and lower incidence of side-effects, as evaluated by a lower incidence renal and allergic complications.

Secondary

MeasureTime frame
Reduced costs of endovascular procedures for treating patients with vascular disease treated by National Health System (SUS), through the use of new contrast medium for lower cost.

Countries

Brazil

Contacts

Public ContactNelson;Nelson Wolosker;Wolosker

Hospital Israelita Albert Einstein;Hospital Israelita Albert Einstein

nwolosker@yahoo.com.br;nwolosker@yahoo.com.br11- 21515423;11 2151-5423

Outcome results

None listed

Source: REBEC (via WHO ICTRP)